{"schema_version":1,"research_id":"eoa_inverse_innovation_exp06_external_evaluation_20260803","source_assessment_id":"predictive_residual_processing__criminology_forensic:P3:v0","cell_id":"predictive_residual_processing__criminology_forensic","search_queries":["site:nist.gov forensic toxicology quality assurance analytical batch controls OSAC standard","forensic toxicology laboratory guidelines quality control chromatograms carryover ion ratio retention time official","multivariate quality control LC-MS analytical batch anomaly detection retention time internal standard forensic toxicology","forensic toxicology workload backlog laboratory quality review report","ANSI ASB 054 2021 PDF quality control forensic toxicology laboratories batch carryover internal standard","ANSI ASB 113 identification criteria forensic toxicology PDF retention time ion ratio","site:soft-tox.org laboratory guidelines forensic toxicology quality assurance PDF 2024","forensic toxicology multivariate statistical process control LC-MS quality control residual model paper","\"Method design and automation\" \"112919\" forensic toxicology authors","\"AutoQ4MS\" automated quality control mass spectrometry authors 2026","site:pubmed.ncbi.nlm.nih.gov \"Automated Near Real-Time QC for LC-HRMS\"","site:pubmed.ncbi.nlm.nih.gov \"Method design and automation of a forensic toxicology\""],"sources":[{"source_id":"S1","title":"ANSI/ASB Standard 054: Standard for a Quality Control Program in Forensic Toxicology Laboratories","publisher":"American Academy of Forensic Sciences Standards Board","url":"https://www.aafs.org/asb-standard/standard-quality-control-program-forensic-toxicology-laboratories","source_class":"STANDARD","publication_date":"2021","accessed_at":"2026-08-03","claims_supported":["Forensic toxicology laboratories are expected to maintain quality-control programs covering calibrators and controls.","The standard directs laboratories to review and monitor quality-control data.","The proposed residual layer would be supplementary to, rather than a replacement for, established QC requirements."]},{"source_id":"S2","title":"Forensic science activities: statutory code of practice—version 2","publisher":"UK Forensic Science Regulator, Home Office","url":"https://www.gov.uk/government/publications/forensic-science-activities-statutory-code-of-practice-version-2/forensic-science-activities-statutory-code-of-practice-version-2-accessible","source_class":"GOVERNMENT_OR_REGULATOR","publication_date":"2025-06-05","accessed_at":"2026-08-03","claims_supported":["Forensic quality failures can prejudice investigations or proceedings and may affect hundreds or thousands of results when systemic.","A senior accountable individual has authority and responsibility for quality risks and resource deployment.","Drug-toxicology requirements address analytical-batch separation, carryover, blanks, retention time, ion ratios, internal-standard response, uncertainty and ongoing QC.","Forensic units must use valid methods, controlled procedures, audit and sufficient resources."]},{"source_id":"S3","title":"Needs Assessment of Forensic Laboratories and Medical Examiner/Coroner Offices: A Report to Congress","publisher":"Office of Justice Programs, U.S. Department of Justice","url":"https://ojp.gov/library/publications/needs-assessment-forensic-laboratories-and-medical-examinercoroner-offices","source_class":"GOVERNMENT_OR_REGULATOR","publication_date":"2019-01-01","accessed_at":"2026-08-03","claims_supported":["Public forensic laboratories and medical-examiner/coroner offices report workload, backlog, personnel, equipment and funding needs.","Expressed needs include processing increasing evidence volumes, addressing opioid-related workload, strengthening quality assurance and limiting preventable nonconformities.","Public laboratories, medical-examiner offices, NIJ and other justice funders are identifiable stakeholder and funding classes."]},{"source_id":"S4","title":"Method design and automation of a forensic toxicology LC-QTOF-MS technique to meet high-throughput routine applications","publisher":"Forensic Science International / Elsevier; indexed by PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/41832870/","source_class":"PRIMARY_RESEARCH","publication_date":"2026-03-10","accessed_at":"2026-08-03","claims_supported":["The San Francisco Office of the Chief Medical Examiner developed and validated automated forensic-toxicology data processing for routine high-throughput work.","The system evaluates calibration, retention time, internal-standard stability, QC performance and measurement uncertainty using lookup tables, calculations and automated flags.","Implementation reportedly reduced review time from several days to three hours per analytical batch while improving consistency and standards alignment.","The work identifies a concrete adopter and a California Department of Public Health funder.","It is close prior art, although it does not report the proposal's full joint residual, independent raw-audit and automatic decompression architecture."]},{"source_id":"S5","title":"Automated Near Real-Time QC for LC-HRMS","publisher":"Rapid Communications in Mass Spectrometry / Wiley","url":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/rcm.70052","source_class":"PRIMARY_RESEARCH","publication_date":"2026-05-30","accessed_at":"2026-08-03","claims_supported":["AutoQ4MS compares internal-standard retention time, peak intensity and mass error with rolling method-specific expectations.","It uses multivariate statistical process control, configurable limits, alerts, a database and a dashboard, demonstrating technical feasibility for automated residual-like LC-HRMS monitoring.","Retrospective evaluation covered five years of measurements.","Laboratory staff found important conditions, including high blank values and elevated total-ion current, that the automated workflow did not flag, demonstrating model-scope and raw-review hazards.","The authors caution that an anomaly does not necessarily invalidate a measurement and that underlying values require review."]},{"source_id":"S6","title":"Application of professional best practices in postmortem forensic toxicology","publisher":"Journal of Analytical Toxicology / Oxford University Press","url":"https://academic.oup.com/jat/article/49/8/529/8195729","source_class":"AUTHORITATIVE_SECONDARY","publication_date":"2025-07-09","accessed_at":"2026-08-03","claims_supported":["Forensic toxicology uses multiple validated chromatographic and mass-spectrometric techniques and consensus standards.","A different qualified individual should technically review each analytical batch under written, consistent procedures.","Review includes calibrators, controls, samples, failures, deviations and reportability; isolated QC failures can require contextual judgment rather than automatic batch rejection.","Human factors and cognitive bias can influence forensic-toxicology decisions.","The article identifies laboratory directors, toxicologists, technical reviewers, medical examiners and coroners as relevant adopters or authorizers."]},{"source_id":"S7","title":"Toxicology: analysis for drugs (FSR-GUI-0029)","publisher":"UK Forensic Science Regulator, Home Office","url":"https://www.gov.uk/government/publications/toxicology-analysis-for-drugs-fsr-gui-0029/toxicology-analysis-for-drugs-fsr-gui-0029-accessible","source_class":"OFFICIAL_GUIDANCE","publication_date":"2026-06-01","accessed_at":"2026-08-03","claims_supported":["The guidance followed significant quality failures in drug-driving toxicology and addresses remaining scientific challenges.","Unexpected peaks at the correct retention time with acceptable ion ratios may indicate contamination and require investigation regardless of peak area.","Recurring contamination can require stopping analysis, and contaminated results must not merely be numerically adjusted.","The guidance demonstrates both the materiality of structured batch context and the need to keep rule-based protected bypasses authoritative."]},{"source_id":"S8","title":"Human Factors in Validation and Performance Testing of Forensic Science","publisher":"Organization of Scientific Area Committees for Forensic Science, National Institute of Standards and Technology","url":"https://www.nist.gov/system/files/documents/2023/10/26/OSACTechSeriesPub_HF%20in%20Validation%20and%20Performance%20Testing%20of%20Forensic%20Science_March2020.pdf","source_class":"OFFICIAL_GUIDANCE","publication_date":"2020-03","accessed_at":"2026-08-03","claims_supported":["Forensic validation should measure both reliability and validity, including sensitivity and specificity where appropriate.","Independent replication and retesting of casework-like samples can reveal laboratory or examiner inconsistencies.","Disagreements can identify equipment, controls, environmental, training, threshold or validity-boundary problems.","Empirical studies with known-source specimens can compare decision thresholds and inform procedure improvement."]}],"problem_evidence":{"support":"STRONG","rationale":"The problem is visible at both system and batch levels. U.S. justice-system evidence documents workload, backlog, funding and quality-assurance needs; current forensic-toxicology practice requires qualified batch review across numerous controls and measurements; a 2026 forensic laboratory implementation reports that manual HRMS processing took days and was vulnerable to error; and current regulatory guidance was issued after significant toxicology quality failures. Sources establish importance but do not quantify how often fixed-rule review misses the specific correlated within-limit patterns hypothesized by the proposal.","source_ids":["S2","S3","S4","S6","S7"]},"stakeholder_evidence":{"support":"STRONG","rationale":"The San Francisco Office of the Chief Medical Examiner is an identifiable adopter that implemented adjacent automated batch review, and the California Department of Public Health funded that work. Laboratory directors or senior accountable individuals possess quality-system authority, while DOJ/NIJ evidence records demand for workload relief and stronger QA. Pull is strong for automation and QA improvement, but no source explicitly requests this exact frozen joint-predictor, residual-first and raw-audit configuration.","source_ids":["S2","S3","S4","S6"]},"prior_art":{"proximity":"SUBSTANTIAL_COLLISION","closest_analogues":[{"name":"San Francisco OCME automated LC-QTOF-MS forensic-toxicology workflow","similarity":"Same forensic-toxicology batch setting; automates evaluation of calibration, retention time, internal-standard stability, QC, uncertainty and exception handling; integrates with laboratory systems and reports substantial review-time reduction.","remaining_difference":"Uses reference comparisons, lookup tables and automated flags rather than a documented frozen joint predictor with signed covariance-aware residuals, residual-plus-baseline reconstruction, independent random raw review and automatic full-review decompression.","source_ids":["S4"]},{"name":"AutoQ4MS automated near-real-time LC-HRMS quality control","similarity":"Maintains rolling method-specific expectations, computes multivariate statistical-process-control deviations for retention time, intensity and mass error, issues alerts and retains dashboard telemetry.","remaining_difference":"Was evaluated in environmental surveillance rather than forensic casework; its uncovered blind spots show that it lacks the proposal's complete protected-bypass and independent raw-audit assurance, and it does not establish residual-first reviewer performance.","source_ids":["S5"]},{"name":"ANSI/ASB 054 plus conventional qualified technical batch review","similarity":"Already requires QC materials, calibrators, controls and review and monitoring of QC data; professional practice adds independent qualified review of the batch, deviations and reportability.","remaining_difference":"Does not itself specify a synchronized multivariate predictive representation, structured signed residual queue, model-scope checks or randomized shadow raw-review channel.","source_ids":["S1","S6"]},{"name":"Forensic Science Regulator toxicology rules and contamination guidance","similarity":"Uses batch context, blanks, internal-standard response, retention-time and ion-ratio criteria, contamination investigation, uncertainty and stop/repeat rules.","remaining_difference":"Predominantly fixed requirements and contextual human investigation rather than learned joint expectations and precision-weighted residual prioritization; these rules must remain protected bypasses under the proposal.","source_ids":["S2","S7"]}],"distinctive_claim_remaining":"For one frozen method, a residual-first interface combining a scoped joint predictor, signed sequence-aware residuals, compatible baseline reconstruction, independent randomized raw-trace review and mandatory full-review fallback will reduce qualified-reviewer time by a predeclared amount without missing any protected QC or integrity condition, reducing material-pattern sensitivity, increasing false escalation or inducing unsupported forensic conclusions relative to both complete standard review and an AutoQ4MS-style rules/MSPC interface. This is a narrow, contrastive and falsifiable performance-and-safety claim, not an established novelty claim.","confidence":"HIGH"},"implementation_evidence":{"support":"MODERATE","rationale":"The core feature extraction, automated QC, multivariate monitoring, alerting, database and interface components have been implemented in adjacent LC-HRMS systems, including routine forensic casework. Standards provide usable protected-bypass conditions and governance roles. A read-only retrospective study is therefore technically and procedurally feasible. Unverified elements include access to authenticated raw case data, stable labels for subtle batch-level patterns, method-specific covariance calibration, independence of raw audits, human-interface effects, local validation/accreditation treatment and net maintenance burden. Live use cannot be justified from web evidence.","source_ids":["S1","S2","S4","S5","S6","S7","S8"]},"scores":{"meaningful_impact":{"score":4,"rationale":"Forensic quality failures can affect justice outcomes and systemic failures can implicate many results; reducing multi-day batch review while preserving quality could be consequential.","source_ids":["S2","S3","S4","S7"]},"stakeholder_pull":{"score":4,"rationale":"A named public forensic laboratory and public-health funder have implemented and financed close automation, while official needs assessments call for workload capacity and stronger QA.","source_ids":["S3","S4"]},"incremental_advantage":{"score":2,"rationale":"Rule-based forensic automation and multivariate LC-HRMS QC already cover much of the functional core. Advantage depends on untested raw-audit, reconstruction and reviewer-performance gains.","source_ids":["S4","S5"]},"distinctiveness_plausibility":{"score":2,"rationale":"The full governance bundle is distinguishable, but its technical ingredients are established and two recent systems substantially collide with the central residual-monitoring concept.","source_ids":["S4","S5","S8"]},"technical_implementability":{"score":4,"rationale":"Recent primary studies demonstrate implementable feature extraction, multivariate monitoring, exception handling, databases and forensic workflow integration.","source_ids":["S4","S5"]},"adoption_authority_feasibility":{"score":3,"rationale":"Laboratory directors or senior quality leaders can authorize retrospective validation, but live deployment must remain subordinate to validated methods, accreditation, technical review and jurisdiction-specific rules.","source_ids":["S1","S2","S6"]},"evidence_readiness":{"score":3,"rationale":"A bounded study design and comparators are available, but raw files, adjudicated outcomes and qualified reviewers are generally proprietary or require a laboratory partnership.","source_ids":["S4","S6","S8"]},"safety_net_benefit":{"score":4,"rationale":"Independent raw review, protected rule bypasses and automatic fallback directly address automation blind spots documented in adjacent work and preserve human authority.","source_ids":["S5","S6","S7","S8"]},"scalability":{"score":3,"rationale":"Software components are reusable, but every method, instrument, matrix, lot regime and laboratory quality system requires scoped validation and continuing monitoring.","source_ids":["S1","S4","S5","S6"]}},"score_confidence":"MODERATE","costs":{"first_evidence":{"band_2026_usd":"250K_TO_1M","scope":"Build a read-only prototype for one frozen method and conduct the pre-registered three-arm retrospective crossover study, including data engineering, feature validation, security review, qualified-reviewer time, statistical analysis and independent raw audits.","confidence":"LOW","assumptions":["One laboratory supplies 80 legally reusable completed or synthetic batches and four to six qualified reviewers.","Existing instrument exports and laboratory infrastructure are reusable.","No instrument purchase, live case decision or regulatory submission is included.","The band is a resource-equivalent estimate; no direct vendor quote or published labor breakdown was found."],"source_ids":["S4","S5","S6","S8"]},"initial_deployment_startup":{"band_2026_usd":"250K_TO_1M","scope":"After successful evidence, integrate one validated method with the laboratory information system, identity/access controls, immutable provenance, model-version checks, fallback paths, validation documentation and quality-management change control.","confidence":"LOW","assumptions":["Deployment is limited to one method, one instrument family and one laboratory.","Existing data storage and case-management systems expose usable interfaces.","The predictor remains read-only and cannot release or invalidate results.","Accreditation consultation is included but not major instrument replacement or litigation."],"source_ids":["S1","S2","S4"]},"operational_launch":{"band_2026_usd":"250K_TO_1M","scope":"Parallel operation, staff training, competency assessment, expanded validation across declared lots and matrices, incident drills, audit review and technical-leader approval for a single-laboratory launch.","confidence":"LOW","assumptions":["Three to six months of parallel complete review is required.","All protected conditions continue through existing rules.","Launch includes reviewer-interface support and model rollback capability.","No multi-site harmonization is included."],"source_ids":["S2","S4","S6","S8"]},"annual_recurring":{"band_2026_usd":"50K_TO_250K","scope":"Software hosting and support, model and method version governance, periodic calibration and drift review, random raw audits, proficiency exercises, security maintenance and quality-manager oversight for one method.","confidence":"LOW","assumptions":["Approximately 0.5 to 1.5 combined FTE of toxicology, quality, data and engineering effort is required.","No recurring instrument acquisition or laboratory-wide platform replacement is included.","A major method change would trigger a separate revalidation project.","Cost savings from reduced review time are not credited because they remain unmeasured."],"source_ids":["S1","S3","S4","S5","S6"]}},"verified_pipeline_gates":{"externally_supported_problem":{"status":"YES","reason":"Official needs evidence, current regulatory guidance and primary forensic-laboratory research establish workload, review complexity and material quality risks.","source_ids":["S2","S3","S4","S6","S7"]},"externally_credible_adopter_or_authorizer":{"status":"YES","reason":"The San Francisco OCME is a demonstrated adopter of adjacent automation; its laboratory leadership and comparable laboratory directors are credible authorizers, and a public-health agency funded the cited implementation.","source_ids":["S2","S4","S6"]},"distinct_testable_incremental_claim":{"status":"YES","reason":"The remaining claim can be tested against complete standard review and a rule/MSPC interface using protected-condition recall, material-pattern sensitivity, review time, false escalation, audit disagreement and interpretation errors.","source_ids":["S4","S5","S8"]},"bounded_next_evidence_step":{"status":"YES","reason":"A one-method, offline, frozen-model crossover using completed or synthetic batches is bounded and authorizes no case or batch decision.","source_ids":["S4","S6","S8"]},"no_unresolved_safety_or_authority_stop":{"status":"YES","reason":"For the retrospective shadow study only, raw data and existing conclusions remain authoritative, protected rules bypass the model, qualified humans retain decisions and any material miss halts testing. This gate does not authorize live use.","source_ids":["S1","S2","S6","S7","S8"]},"credible_cost_scope_and_range":{"status":"UNCERTAIN","reason":"Software and workflow components bound the required work, but no source supplies a directly transferable labor, integration, validation or audit cost for this architecture. Bands are bottom-up resource-equivalent estimates rather than quoted budgets.","source_ids":["S3","S4","S5","S6"]}},"next_evidence_step":"With one laboratory partner, pre-register an offline three-arm crossover on one frozen LC-QTOF-MS method using 80 approved completed or synthetic batches, including at least 30 batches with independently adjudicated or seeded response drift, retention-time shift, internal-standard suppression, carryover, blank contamination, correlated ion-ratio change, missing injection, processing-version mismatch, interference, instrument interruption or benign unusual traces. Freeze feature extraction, model, thresholds, error budget and bypass table before a temporally separated holdout. Four to six blinded qualified reviewers examine randomized batches under: (A) the validated method and complete review; (B) the same data with standards/vendor-rule plus AutoQ4MS-style MSPC flags; and (C) the proposed residual-first interface with full-data access. Measure protected-condition misses, material-pattern sensitivity, median review time, false escalations, raw-audit disagreements, reconstruction error by regime, calibration, fallback operation, reviewer agreement, unsupported specimen or case interpretations and maintenance effort. Falsify the incremental claim on any unexplained protected-condition miss or inaccessible raw context; a greater-than-5-percentage-point sensitivity loss versus complete review; a material feature found only by independent raw audit; any residual-driven forensic conclusion; failure of version mismatch or fallback tests; or less than 20% median review-time reduction after including audit and maintenance effort.","blocking_evidence":["No published head-to-head evaluation compares the complete proposed architecture with both qualified complete review and a strong automated rules/MSPC comparator.","The prevalence and consequences of correlated within-limit batch patterns that existing review misses are not quantified.","Authenticated raw traces, sequence metadata and technically adjudicated outcomes require laboratory-controlled or proprietary data access.","Subgroup and regime performance across matrices, concentration ranges, instruments, lots and maintenance states is unknown.","Human-interface effects, including loss of baseline context and automation bias, require qualified-reviewer testing.","Local U.S. accreditation, disclosure, records-retention and change-control treatment must be determined for the intended laboratory; UK regulatory sources are informative but not controlling in the United States.","No directly sourced 2026 implementation or recurring-cost estimate exists."],"research_disposition":"PARTNERED_RESEARCH_PROGRAM","world_novelty_boundary":"The search measured only visible problem evidence, stakeholder pull, feasibility and close public prior art. It found substantial collision with 2026 forensic automation and multivariate LC-HRMS QC, leaving a narrow untested governance-and-performance contrast. World novelty, patentability, freedom to operate, market size and realized impact remain unmeasured.","arm":"COMPLETE_PROPOSAL_PORTFOLIO","candidate_version":0,"controller_recommendation":{"action":"STOP_EMPIRICAL_RESEARCH_NEEDED","repairable":false,"material_progress_observed":true,"progress_targets":["Secure a laboratory data-use and reviewer-participation agreement for one frozen method.","Pre-register the three-arm protocol, protected-condition taxonomy, stopping rules, analysis plan and cost accounting before accessing the holdout.","Demonstrate reproducible feature extraction, raw-context reconstruction, version-mismatch rejection and forced fallback on synthetic test batches.","Complete the blinded crossover and report all protected misses, sensitivity differences, review-time effects, false escalations, audit disagreements and unsupported interpretations by regime.","Obtain written quality-leader and accreditation-path review before considering any prospective or live workflow use.","Produce an evidence-based total-cost-of-ownership estimate including validation, audit, fallback and model-maintenance labor."],"reason":"Bounded web research establishes a real problem, credible adopters and technical feasibility, but also finds substantial prior-art overlap. Whether the remaining raw-audited residual-first architecture is safer or more efficient requires proprietary batch data and qualified-reviewer experimentation, which cannot be resolved by further web search. Under the required controller rule this is an empirical-research stop, not a request for ordinary web repair."},"proposal_index":3}